{"id":"W2900677307","doi":"10.1177/1203475418814229","title":"Ixekizumab (Interleukin 17A Antagonist): 12-week Efficacy and Safety Outcomes in Real-world Clinical Practice","year":2018,"lang":"en","type":"article","venue":"Journal of Cutaneous Medicine and Surgery","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":20,"is_retracted":false,"has_abstract":true,"ca_institutions":"Probity Medical Research; Health Sciences Centre; Women's College Hospital; University of Toronto; Sunnybrook Health Science Centre; Western University","funders":"","keywords":"Ixekizumab; Medicine; Erythema; Randomized controlled trial; Psoriasis; Adverse effect; Clinical trial; Psoriasis Area and Severity Index; Internal medicine; Physical therapy; Dermatology; Secukinumab; Psoriatic arthritis","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.03235009,0.0002549571,0.0007691768,0.0008906879,0.0004493814,0.001550042,0.0004351923,0.0009371047,0.002745778],"category_scores_gemma":[0.05474051,0.0002044377,0.0007489431,0.001163393,0.000834716,0.001273074,0.0008289646,0.0007208329,0.0005011884],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.001147327,"about_ca_system_score_gemma":0.001591751,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0004893256,"about_ca_topic_score_gemma":0.0003657893,"domain_scores_codex":[0.9772593,0.01491019,0.003397958,0.001270045,0.002732407,0.0004302032],"domain_scores_gemma":[0.9364967,0.02412167,0.0305673,0.001968436,0.005064497,0.00178133],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.02360489,0.004295651,0.741141,0.003711522,0.001704218,0.0002928824,0.001711256,0.001245597,0.001331044,0.0004895025,0.002441285,0.2180311],"study_design_scores_gemma":[0.007244777,0.05901109,0.9096443,0.002006105,0.001760445,0.002697183,0.001617064,0.003347659,0.00276305,0.001121666,0.00864899,0.0001377174],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9671602,0.02245579,0.001845252,0.001719796,0.00007657486,0.000843241,0.0008887958,0.00003699904,0.004973289],"genre_scores_gemma":[0.9959581,0.001751624,0.001235939,0.0002045404,0.0000729474,0.0002926725,0.0002965876,0.000005284805,0.0001822606],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.03235009,"threshold_uncertainty_score":0.1710857,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05074219753956134,"score_gpt":0.3404001503373068,"score_spread":0.2896579527977454,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}